Pharmaceutical News

Titan Pharmaceuticals has announced the results of a six-month safety re-treatment study (PRO-811) of probuphine in patients with opioid dependence. [...]

Tekmira Pharmaceuticals has received two US patents, one covering its lipid nanoparticle (LNP) delivery technology, and the other covering the chemical modification of siRNA to mitigate immune stimulation. [...]

StayinFront, a provider of CRM systems, has announced expanded agreement with a New Jersey-based global biotechnology firm to include a range of technical services to support its entire enterprise. [...]

Sigma-Aldrich has reported a profit of $108m, or 89 cents a share, for the fourth quarter of 2011 compared to $94m, or 76 cents a share, for the same quarter of previous year. [...]

AVI BioPharma has reported the positive safety results from all six dose cohorts in the single ascending dose studies of its AVI-6002 and AVI-6003, being investigated for the treatment of Ebola virus and Marburg virus, respectively. [...]

Rock Creek Pharmaceuticals has initiated second multi-site clinical trial to demonstrate the potential role for nutritional supplementation with its Anatabloc formulation in supporting immune health. [...]

Genmab has reached the second pre-clinical milestone in the collaboration with Lundbeck, triggering a €1m payment. [...]

Branham Law Group, a US law firm, is investigating Pfizer for its recall of 14 lots of Lo/Ovral-28 tablet packs and 14 lots of generic Norgestrel and Ethinyl Estradiol tablets. [...]

BioSante Pharmaceuticals has announced that the independent Data Monitoring Committee (DMC) has completed the eighth unblinded review of the LibiGel Phase III cardiovascular and breast cancer safety study. [...]

The Scottish government and Pharmaceutical Product Development (PPD) have formed an alliance to advance the development of new medical therapies and improve health care treatment options for the people of Scotland. [...]